Towards a clinical staging for bipolar disorder: Defining patient subtypes based on functional outcome |
| |
Authors: | María Reinares Efstathios Papachristou Philip Harvey C. Mar Bonnín José Sánchez-Moreno Carla Torrent José L. Ayuso-Mateos George B. Ploubidis Eduard Vieta Sophia Frangou |
| |
Affiliation: | 1. Bipolar Disorders Program, Institute of Neurosciences, Hospital Clínic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain;2. Section of Neurobiology of Psychosis, Department of Psychosis Studies, Institute of Psychiatry, King''s College London, SE5 8AF, UK;3. Division of Psychology, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine, University of Miami, FL 33136, USA;4. Department of Psychiatry, Universidad Autónoma de Madrid, CIBERSAM, Madrid, Spain;5. Department of Population Studies, London School of Hygiene and Tropical Medicine, University College London, WC1E 7HT, UK |
| |
Abstract: | BackgroundThe functional outcome of Bipolar Disorder (BD) is highly variable. This variability has been attributed to multiple demographic, clinical and cognitive factors. The critical next step is to identify combinations of predictors that can be used to specify prognostic subtypes, thus providing a basis for a staging classification in BD.MethodsLatent Class Analysis was applied to multiple predictors of functional outcome in a sample of 106 remitted adults with BD.ResultsWe identified two subtypes of patients presenting “good” (n=50; 47.6%) and “poor” (n=56; 52.4%) outcome. Episode density, level of residual depressive symptoms, estimated verbal intelligence and inhibitory control emerged as the most significant predictors of subtype membership at the p<0.05 level. Their odds ratio (OR) and confidence interval (CI) with reference to the “good” outcome group were: episode density (OR=4.622, CI 1.592–13.418), level of residual depressive symptoms (OR=1.543, CI 1.210–1.969), estimated verbal intelligence (OR=0.969; CI 0.945–0.995), and inhibitory control (OR=0.771, CI 0.656–0.907). Age, age of onset and duration of illness were comparable between prognostic groups.LimitationsThe longitudinal stability or evolution of the subtypes was not tested.ConclusionsOur findings provide the first empirically derived staging classification of BD based on two underlying dimensions, one for illness severity and another for cognitive function. This approach can be further developed by expanding the dimensions included and testing the reproducibility and prospective prognostic value of the emerging classes. Developing a disease staging system for BD will allow individualised treatment planning for patients and selection of more homogeneous patient groups for research purposes. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|